TABLE I.
Patient characteristics at baseline
| Characteristic | Patient group | ||
|---|---|---|---|
|
| |||
| eLCSS-QL | Standard | Overall | |
| Patients (n) | 44 | 51 | 95 |
|
| |||
| Sex [n (%)] | |||
| Men | 25 (57) | 28 (55) | 53 (56) |
| Women | 19 (43) | 23 (45) | 42 (44) |
|
| |||
| Age (years) | |||
| Median | 63 | 67 | 65 |
| Range | 43–80 | 39–80 | 39–80 |
|
| |||
| Stage [n (%)] | |||
| IIIB | 21 (48) | 21 (41) | 42 (44) |
| IV | 23 (52) | 30 (59) | 53 (56) |
|
| |||
| ECOG PS [n (%)] | |||
| 0–1 | 30 (68) | 30 (59) | 60 (63) |
| 2–3 | 14 (32) | 21 (41) | 35 (37) |
|
| |||
| Chemotherapy regimen [n (%)] | |||
| Platinum doublet | 36 (82) | 45 (88) | 81 (85) |
| Non-platinum-based | 8 (18) | 6 (12) | 14 (15) |
|
| |||
| Mean HRQoL | |||
| Baseline (900 maximum) | 582±151 | 628±128 | 607±140 |
| Global (100 maximum) | 46±25 | 60±22 | 53±24 |
eLCSS-QL = electronic Lung Cancer System Scale for quality-of-life assessment; ECOG PS = Eastern Cooperative Oncology Group performance status; HRQoL = health-related quality of life.